Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of

Khaliq H Kurji1, Jing Z Cui, Tony Lin

  • 1Department of Ophthalmology and Visual Sciences, University of British Columbia, British Columbia, Canada.

Abstract

Insights

Amyloid beta (Abeta) peptide, a drusen component, triggers gene expression changes in retinal pigment epithelium (RPE) cells, primarily activating immune and inflammatory pathways relevant to age-related macular degeneration (AMD) pathogenesis.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older adults.
  • Drusen, characteristic deposits in AMD, contain amyloid beta (Abeta) peptides.
  • The role of Abeta in AMD pathogenesis requires further elucidation at the cellular level.

Purpose of the Study:

  • To investigate the in vitro effects of Abeta(1-40) on retinal pigment epithelium (RPE) cell gene expression.
  • To determine if Abeta(1-40) stimulation alters pathways implicated in AMD, such as oxidative stress, inflammation, and angiogenesis.
  • To test the hypothesis that Abeta(1-40) influences RPE cells in ways relevant to AMD development.

Main Methods:

  • Human RPE cells were stimulated with Abeta(1-40) or a control peptide (Abeta(40-1)).
  • Genome-wide gene expression changes were analyzed using microarrays.
  • Quantitative real-time PCR (qRT-PCR) and ELISA were used for gene and protein validation.
  • Pathway analysis was performed using Gene Set Enrichment Analysis (GSEA) and Ingenuity.

Main Results:

  • Abeta(1-40) stimulation upregulated 63 genes and downregulated 22 genes in RPE cells.
  • Upregulated genes were mainly involved in inflammatory and immune responses, apoptosis, and cell signaling.
  • Secreted IL-8 levels increased twofold, and pathway analysis confirmed inflammation and immune response as top affected pathways.
  • Angiogenic pathways were minimally affected at the tested doses and durations.

Conclusions:

  • Abeta(1-40) significantly alters RPE gene expression, particularly activating immune response, inflammation, and cytokine/interferon signaling pathways.
  • These findings suggest a potential mechanism by which Abeta contributes to AMD pathogenesis in vivo.
  • The study highlights the inflammatory role of Abeta in RPE cells relevant to AMD.

Related Concept Videos